Genesis MedTech Group

Founded in Singapore in 2019 by experienced industry professionals, Genesis MedTech Group is a medical device company led by Chairman and CEO Warren Wang. The enterprise develops technologies for surgical, vascular interventions, and structural heart solutions, with Mark Turco serving as President of Genesis MedTech Intervention North America and CEO of JC Medical. Backed by venture funding, the organization secured a Series B financing round led by General Atlantic with participation from CITIC Capital to expand its multi-therapy medical portfolio. The company manages the full product lifecycle from research to commercialization, generating approximately $22.1 million in annual revenue and employing a global workforce of approximately 2,019 individuals. By integrating research, production, quality management, and established commercial networks, the business delivers advanced, affordable medical technologies to healthcare practitioners and patients across developed and emerging markets worldwide.